libri scuola books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro
ARGOMENTO:  BOOKS > BIOLOGIA > BIOTECNOLOGIE

faye loïc (curatore); gomord veronique (curatore) - recombinant proteins from plants

Recombinant Proteins From Plants Methods and Protocols

;




Disponibilità: Normalmente disponibile in 15 giorni
A causa di problematiche nell'approvvigionamento legate alla Brexit sono possibili ritardi nelle consegne.


PREZZO
108,98 €
NICEPRICE
103,53 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

Humana Press

Pubblicazione: 12/2010
Edizione: Softcover reprint of hardcover 1st ed. 2009





Trama

Altogether, the biochemical, technical and economic limitations on existing proka- otic and eukaryotic expression systems and the growing clinical demand for complex therapeutic proteins have created substantial interest in developing new expression systems for the production of therapeutic proteins. To that end, plants have emerged in the past decade as a suitable alternative to the current production systems, and today their potential for production of high quality, much safer and biologically active complex recombinant pharmaceutical proteins is largely documented. The chapters in this volume, contributed by leaders in the field, sum up the state-- the-art methods for using a variety of different plants as expression hosts for phar- ceutical proteins. Several production platforms are presented, ranging from seed- and leaf-based production in stable transgenic plant lines, to plant cell bioreactors, to viral or Agrobacterium-mediated transient expr ession systems. Currently, antibodies and their derived fragments represent the largest and most important group of biote- nological products in clinical trials. This explains why the potential of most prod- tion platforms is illustrated here principally for antibodies or antibody fragments with acknowledged potential for immunotherapy in humans. In addition, a comparison of different plant expression systems is presented using aprotinin, a commercial phar- ceutical protein, as a test system. Although multiple books and monographs have been recently published on mol- ular pharming, there is a noticeable dearth of bench step-by-step protocols that can be used quickly and easily by beginners entering this new field.




Sommario

From Neanderthal to Nanobiotech: From Plant Potions to Pharming with Plant Factories.- Cowpea Mosaic Virus-Based Systems for the Expression of Antigens and Antibodies in Plants.- Transient Expression of Antibodies in Plants Using Syringe Agroinfiltration.- Rapid System for Evaluating Bioproduction Capacity of Complex Pharmaceutical Proteins in Plants.- Production and Localization of Recombinant Pharmaceuticals in Transgenic Seeds.- Production of Antibody Fragments in Arabidopsis Seeds.- Production of Plantibodies in Nicotiana Plants.- Physcomitrella patens : A Non-Vascular Plant for Recombinant Protein Production.- Production of Recombinant Proteins in Suspension–Cultured Plant Cells.- Chloroplast-Derived Vaccine Antigens and Biopharmaceuticals: Protocols for Expression, Purification, or Oral Delivery and Functional Evaluation.- Protein Body Induction: A New Tool to Produce and Recover Recombinant Proteins in Plants.- A Case Study for Plant-Made Pharmaceuticals Comparing Different Plant Expression and Production Systems.- Glycosylation of Antibody Therapeutics: Optimisation for Purpose.- N-Glycosylation of Plant Recombinant Pharmaceuticals.- Companion Protease Inhibitors to Protect Recombinant Proteins in Transgenic Plant Extracts.- Strategies for Improving Vaccine Antigens Expression in Transgenic Plants: Fusion to Carrier Sequences.- Immunomodulation of Plant Function by In Vitro Selected Single-Chain Fv Intrabodies.- On-Chip Detection of Low-Molecular-Weight Recombinant Proteins in Plant Crude Extracts by SELDI-TOF MS.- Assessing the Risk of Undesirable Immunogenicity/ Allergenicity of Plant-Derived Therapeutic Proteins.- Biosafety, Risk Assessment and Regulation of Plant-Made Pharmaceuticals.










Altre Informazioni

ISBN:

9781617378645

Condizione: Nuovo
Collana: Methods in Molecular Biology
Dimensioni: 260 x 193 mm
Formato: Brossura
Illustration Notes:XVII, 358 p.
Pagine Arabe: 358
Pagine Romane: xvii


Dicono di noi